{"id":"https://openalex.org/W2131001269","doi":"https://doi.org/10.1101/gad.187252.112","title":"Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis","display_name":"Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis","publication_year":2012,"publication_date":"2012-05-01","ids":{"openalex":"https://openalex.org/W2131001269","doi":"https://doi.org/10.1101/gad.187252.112","mag":"2131001269","pmid":"https://pubmed.ncbi.nlm.nih.gov/22549727","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3360561"},"language":"en","primary_location":{"id":"doi:10.1101/gad.187252.112","doi":"https://doi.org/10.1101/gad.187252.112","is_oa":true,"landing_page_url":"https://doi.org/10.1101/gad.187252.112","pdf_url":"http://genesdev.cshlp.org/content/26/10/1055.full.pdf","source":{"id":"https://openalex.org/S168778273","display_name":"Genes & Development","issn_l":"0890-9369","issn":["0890-9369","1549-5477"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315909","host_organization_name":"Cold Spring Harbor Laboratory Press","host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes & Development","raw_type":"journal-article"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://genesdev.cshlp.org/content/26/10/1055.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090018793","display_name":"Liesbeth C.W. Vredeveld","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Liesbeth C.W. Vredeveld","raw_affiliation_strings":["Division of Molecular Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands","Division of Molecular Oncology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Molecular Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Division of Molecular Oncology,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067165337","display_name":"Patr\u00edcia A. Possik","orcid":"https://orcid.org/0000-0003-2899-0969","observed_orcids":["https://orcid.org/0000-0003-2899-0969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia A. Possik","raw_affiliation_strings":["Division of Molecular Oncology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Molecular Oncology,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070074553","display_name":"Marjon A. Smit","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marjon A. Smit","raw_affiliation_strings":["Division of Molecular Oncology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Molecular Oncology,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028939350","display_name":"Katrin Meissl","orcid":"https://orcid.org/0000-0003-2731-6657","observed_orcids":["https://orcid.org/0000-0003-2731-6657"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katrin Meissl","raw_affiliation_strings":["Division of Molecular Oncology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Molecular Oncology,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111933438","display_name":"Chrysiis Michaloglou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chrysiis Michaloglou","raw_affiliation_strings":["Division of Molecular Oncology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Molecular Oncology,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043980504","display_name":"Hugo M. Horlings","orcid":"https://orcid.org/0000-0003-4782-8828","observed_orcids":["https://orcid.org/0000-0003-4782-8828"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Hugo M. Horlings","raw_affiliation_strings":["Department of Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078681437","display_name":"Abderrahim Ajouaou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Abderrahim Ajouaou","raw_affiliation_strings":["Department of Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039609387","display_name":"Pim C. Kortman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Pim C. Kortman","raw_affiliation_strings":["Department of Pathology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040249960","display_name":"David L. Dankort","orcid":"https://orcid.org/0000-0002-5862-6829","observed_orcids":["https://orcid.org/0000-0002-5862-6829"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Dankort","raw_affiliation_strings":["Helen Diller Family Comprehensive Cancer Center, Department of Cell and Molecular Pharmacology, University of California at\n                           San Francisco, San Francisco, California 94158, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center, Department of Cell and Molecular Pharmacology, University of California at\n                           San Francisco, San Francisco, California 94158, USA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003652463","display_name":"Martin McMahon","orcid":"https://orcid.org/0000-0003-2812-1042","observed_orcids":["https://orcid.org/0000-0003-2812-1042"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin McMahon","raw_affiliation_strings":["Helen Diller Family Comprehensive Cancer Center, Department of Cell and Molecular Pharmacology, University of California at\n                           San Francisco, San Francisco, California 94158, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center, Department of Cell and Molecular Pharmacology, University of California at\n                           San Francisco, San Francisco, California 94158, USA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109551735","display_name":"Wolter J. Mooi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Wolter J. Mooi","raw_affiliation_strings":["Department of Pathology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077723901","display_name":"Daniel S. Peeper","orcid":"https://orcid.org/0000-0003-1293-3177","observed_orcids":["https://orcid.org/0000-0003-1293-3177"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel S. Peeper","raw_affiliation_strings":["Division of Molecular Oncology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Molecular Oncology,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":258,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"10","first_page":"1055","last_page":"1069"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6600000262260437},{"id":"https://openalex.org/keywords/melanocytic-nevi","display_name":"melanocytic nevi","score":0.9290000200271606},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.9319999814033508},{"id":"https://openalex.org/keywords/oncogene-induced-senescence","display_name":"oncogene-induced senescence","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.9649999737739563},{"id":"https://openalex.org/keywords/akt3","display_name":"AKT3","score":0.9829999804496765},{"id":"https://openalex.org/keywords/melanoma-progression","display_name":"melanoma progression","score":0.5099999904632568},{"id":"https://openalex.org/keywords/nras","display_name":"NRAS","score":0.6230000257492065},{"id":"https://openalex.org/keywords/cdkn2b","display_name":"CDKN2B","score":0.8560000061988831},{"id":"https://openalex.org/keywords/pi3k-inhibition","display_name":"PI3K inhibition","score":0.8349999785423279},{"id":"https://openalex.org/keywords/braf-inhibitor-resistance","display_name":"BRAF inhibitor resistance","score":0.8560000061988831}],"concepts":[{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.8692985773086548},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7784556150436401},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7595164775848389},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7324855327606201},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6384848952293396},{"id":"https://openalex.org/C2779323059","wikidata":"https://www.wikidata.org/wiki/Q692077","display_name":"Nevus","level":3,"score":0.5444884896278381},{"id":"https://openalex.org/C522857546","wikidata":"https://www.wikidata.org/wiki/Q2070979","display_name":"Senescence","level":2,"score":0.543432891368866},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.5341728329658508},{"id":"https://openalex.org/C2776470698","wikidata":"https://www.wikidata.org/wiki/Q21851559","display_name":"V600E","level":4,"score":0.4838194251060486},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.4700160324573517},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.45348048210144043},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.35203275084495544},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.29307302832603455},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22240644693374634},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.19385239481925964},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.16166386008262634},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13303062319755554},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11883792281150818},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.0},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005347","descriptor_name":"Fibroblasts","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005347","descriptor_name":"Fibroblasts","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008544","descriptor_name":"Melanocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008544","descriptor_name":"Melanocytes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009506","descriptor_name":"Nevus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009506","descriptor_name":"Nevus","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016922","descriptor_name":"Cellular Senescence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018698","descriptor_name":"Glutamic Acid","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018698","descriptor_name":"Glutamic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019943","descriptor_name":"Amino Acid Substitution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050762","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p15","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1101/gad.187252.112","doi":"https://doi.org/10.1101/gad.187252.112","is_oa":true,"landing_page_url":"https://doi.org/10.1101/gad.187252.112","pdf_url":"http://genesdev.cshlp.org/content/26/10/1055.full.pdf","source":{"id":"https://openalex.org/S168778273","display_name":"Genes & Development","issn_l":"0890-9369","issn":["0890-9369","1549-5477"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315909","host_organization_name":"Cold Spring Harbor Laboratory Press","host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes & Development","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2495899","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3360561","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3360561","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3360561","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes Dev","raw_type":"Text"},{"id":"pmid:22549727","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22549727","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes & development","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/6e9b0227-9edf-47c2-9299-bc65be7257b3","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/6e9b0227-9edf-47c2-9299-bc65be7257b3","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Vredeveld, L C W, Possik, P A, Smit, M A, Meissl, K, Michaloglou, C, Horlings, H M, Ajouaou, A, Kortman, P C, Dankort, D, McMahon, M, Mooi, W J & Peeper, D S 2012, 'Abrogation of BRAF(V600E)-induced senescence by PI3K pathway activation contributes to melanomagenesis', Genes and Development, vol. 26, no. 10, pp. 1055-1069. https://doi.org/10.1101/gad.187252.112","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/b053dadd-7acb-4bc2-a279-f8a475d98683","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/b053dadd-7acb-4bc2-a279-f8a475d98683","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Genes and Development, 26(10), 1055 - 1069. Cold Spring Harbor Laboratory Press","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1101/gad.187252.112","doi":"https://doi.org/10.1101/gad.187252.112","is_oa":true,"landing_page_url":"https://doi.org/10.1101/gad.187252.112","pdf_url":"http://genesdev.cshlp.org/content/26/10/1055.full.pdf","source":{"id":"https://openalex.org/S168778273","display_name":"Genes & Development","issn_l":"0890-9369","issn":["0890-9369","1549-5477"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315909","host_organization_name":"Cold Spring Harbor Laboratory Press","host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes & Development","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000872090","display_name":"Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy","funder_award_id":"R01CA176839","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320308296","display_name":"Melanoma Research Alliance","ror":"https://ror.org/025ck6r46"},{"id":"https://openalex.org/F4320321800","display_name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","ror":"https://ror.org/04jsz6e67"},{"id":"https://openalex.org/F4320322777","display_name":"KWF Kankerbestrijding","ror":"https://ror.org/0368jnd28"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2131001269.pdf","grobid_xml":"https://content.openalex.org/works/W2131001269.grobid-xml"},"referenced_works_count":66,"referenced_works":["https://openalex.org/W1542257568","https://openalex.org/W1565041471","https://openalex.org/W1756183899","https://openalex.org/W1967909721","https://openalex.org/W1969908659","https://openalex.org/W1970195561","https://openalex.org/W1979165906","https://openalex.org/W1980625127","https://openalex.org/W1982395176","https://openalex.org/W1983348452","https://openalex.org/W1989121777","https://openalex.org/W1991053141","https://openalex.org/W1997073961","https://openalex.org/W1999423655","https://openalex.org/W2000749236","https://openalex.org/W2003753849","https://openalex.org/W2005250235","https://openalex.org/W2011997876","https://openalex.org/W2012090310","https://openalex.org/W2015009944","https://openalex.org/W2018169163","https://openalex.org/W2019544036","https://openalex.org/W2020799240","https://openalex.org/W2022481874","https://openalex.org/W2022891382","https://openalex.org/W2024085992","https://openalex.org/W2028752124","https://openalex.org/W2028994134","https://openalex.org/W2030828521","https://openalex.org/W2034253224","https://openalex.org/W2036110707","https://openalex.org/W2039627657","https://openalex.org/W2040474892","https://openalex.org/W2056578809","https://openalex.org/W2059549347","https://openalex.org/W2059794606","https://openalex.org/W2060162388","https://openalex.org/W2060632243","https://openalex.org/W2065701510","https://openalex.org/W2071113489","https://openalex.org/W2071525523","https://openalex.org/W2074329146","https://openalex.org/W2087999409","https://openalex.org/W2097010979","https://openalex.org/W2107218721","https://openalex.org/W2110466396","https://openalex.org/W2116437342","https://openalex.org/W2123563743","https://openalex.org/W2127120957","https://openalex.org/W2128124648","https://openalex.org/W2129318139","https://openalex.org/W2135838271","https://openalex.org/W2150740687","https://openalex.org/W2153938645","https://openalex.org/W2157833274","https://openalex.org/W2161724145","https://openalex.org/W2162437451","https://openalex.org/W2163188200","https://openalex.org/W2164649851","https://openalex.org/W2169401275","https://openalex.org/W2171733999","https://openalex.org/W2187379309","https://openalex.org/W2315456335","https://openalex.org/W2505643039","https://openalex.org/W4210898159","https://openalex.org/W4244014165"],"related_works":["https://openalex.org/W2109391503","https://openalex.org/W297284523","https://openalex.org/W2100048003","https://openalex.org/W4200201900","https://openalex.org/W2508665420","https://openalex.org/W2024449289","https://openalex.org/W2053295503","https://openalex.org/W2900871448","https://openalex.org/W2625931016","https://openalex.org/W2019544036"],"abstract_inverted_index":{"Human":[0],"melanocytic":[1],"nevi":[2],"(moles)":[3],"are":[4],"benign":[5,85],"lesions":[6],"harboring":[7],"activated":[8,94],"oncogenes,":[9],"including":[10],"BRAF.":[11],"Although":[12],"this":[13,161],"oncogene":[14],"initially":[15],"acts":[16],"mitogenically,":[17],"eventually,":[18],"oncogene-induced":[19],"senescence":[20,45,174],"(OIS)":[21],"ensues.":[22],"Nevi":[23],"can":[24],"infrequently":[25],"progress":[26],"to":[27,106,131,181],"melanomas,":[28],"but":[29],"the":[30,120,191],"mechanistic":[31],"relationship":[32],"with":[33],"OIS":[34],"is":[35],"unclear.":[36],"We":[37],"show":[38],"here":[39],"that":[40,138,151],"PTEN":[41,61,98],"depletion":[42,59],"abrogates":[43],"BRAF(V600E)-induced":[44],"in":[46,52,79,83,103,113,160,166,199],"human":[47,71],"fibroblasts":[48],"and":[49,86,118,176],"melanocytes.":[50,88],"Correspondingly,":[51],"established":[53],"murine":[54],"BRAF(V600E)-driven":[55],"nevi,":[56],"acute":[57],"shRNA-mediated":[58],"of":[60,68,142,173,178,194],"prompted":[62],"tumor":[63,122],"progression.":[64],"Furthermore,":[65,147],"genetic":[66],"analysis":[67],"laser-guided":[69],"microdissected":[70],"contiguous":[72],"nevus-melanoma":[73],"specimens":[74],"recurrently":[75],"revealed":[76],"identical":[77],"mutations":[78],"BRAF":[80],"or":[81,99],"NRAS":[82],"adjacent":[84,108],"malignant":[87],"The":[89,171],"PI3K":[90,111,152,185],"pathway":[91,153],"was":[92],"often":[93],"through":[95],"either":[96],"decreased":[97],"increased":[100],"AKT3":[101],"expression":[102],"melanomas":[104,143],"relative":[105],"their":[107],"nevi.":[109,146],"Pharmacologic":[110],"inhibition":[112,183,186],"melanoma":[114],"cells":[115,179],"suppressed":[116],"proliferation":[117],"induced":[119],"senescence-associated":[121],"suppressor":[123],"p15(INK4B).":[124],"This":[125],"treatment":[126],"also":[127],"eliminated":[128],"subpopulations":[129],"resistant":[130],"targeted":[132],"BRAF(V600E)":[133,182],"inhibition.":[134],"Our":[135],"findings":[136],"suggest":[137],"a":[139,157],"significant":[140],"proportion":[141],"arise":[144],"from":[145],"these":[148,197],"results":[149],"demonstrate":[150],"activation":[154],"serves":[155],"as":[156],"rate-limiting":[158],"event":[159],"setting,":[162],"acting":[163],"at":[164],"least":[165],"part":[167],"by":[168,184],"abrogating":[169],"OIS.":[170],"reactivation":[172],"features":[175],"elimination":[177],"refractory":[180],"warrants":[187],"further":[188],"investigation":[189],"into":[190],"therapeutic":[192],"potential":[193],"simultaneously":[195],"targeting":[196],"pathways":[198],"melanoma.":[200]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":20},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":20},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":27},{"year":2016,"cited_by_count":22},{"year":2015,"cited_by_count":37},{"year":2014,"cited_by_count":29},{"year":2013,"cited_by_count":33},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}